Home / Insights
Insights

Articles, blog notes, and policy updates.

Methodological essays, regulatory commentary, and policy briefs from our biostatisticians, investigators, and health economists.

All Case Studies Articles Blog Policy Updates
Article May 13, 2026

Adaptive design lessons from a Korean Phase II oncology trial

How a Bayesian dose-finding design cut the expected sample size by 28% while preserving operating characteristics — and what we'd do differently next time. A retrospective from ACRO's biostatistics team.

Read Article →
Policy May 11, 2026

MFDS guidance update on RWE submissions

Read Article →
Blog May 4, 2026

When Bayesian endpoints earn their keep

Read Article →

Case studies

Case studies coming soon

We're preparing anonymized snapshots of recent engagements — early-phase study designs, RWE analyses, and regulatory strategy projects. Check back soon, or get in touch to discuss your program directly.